Malaria

Description

USAID leads the President’s Malaria Initiative (PMI), which is co-implemented with the U.S. Centers for Disease Control and Prevention. USAID funding supports malaria prevention and treatment activities in 27 countries throughout Africa and Southeast Asia.

Use of Funds

Funds help develop malaria vaccines, antimalarial drugs, diagnostics, and malaria-related research. Funds support the purchase and delivery of insecticides, insecticide-treated bed nets, and insecticide-spraying in homes.

Justification

• The fight against malaria is one of humanity’s biggest public health successes. Over the last two decades, 1.5 billion cases have been averted, and 7.6 million lives have been saved.
• The most recent World Malaria Report reported an increase of 14 million malaria cases in 2020, totaling 241 million cases of malaria in 2020, up from 229 million cases in 2019.
• In 2020, according to the 2020 Global Technical Strategy for Malaria, the global malaria case incidence was 37% higher than expected, with 56 cases per 1000 population at risk of malaria.
• A child dies of malaria every two minutes. This translates to nearly 750 preventable child deaths under five each day.
• In October 2021, the World Health Organization began recommending “widespread use of a malaria vaccine among children in sub-Saharan Africa and
  in other regions with moderate to high … malaria transmission.” The vaccine has a “high impact in real-life childhood vaccination settings” and is “cost-effective in areas of moderate to high malaria transmission.”